Selection of Representative Engagements

Market Access Solutions:

· Conclusion of more than 30 agreements with
  leading provider of pharmaceutical and healthcare
  and sales services for clients in Biotech, Pharma
  and Diagnostics in Europe and Asia Pacific

Transactions:

· Joint Venture between Spirig Pharma AG,
  Switzerland and Medinova Ltd. (a pharmaceutical
  company of the DKSH Group) for the marketing of
  derma-cosmetics and derma-ceuticals in the
  Asian-Pacific Room

Licensing and Acquisition Searches:

· Assessment of opportunities in the field of
  immunmodulators, cytostatics, minerals and trace
  elements for a Swiss Pharmaceutical Company
· Assessment of licensing opportunities in the field
  of dermatology, oncology, interventional cardiology,
  pain management, for a large Asian Conglomerate with a
  US$ 112 million investment fund
  (ca. 10 transactions close to conclusion)

R&D Collaborations:

· Conclusion of a reputable R&D collaboration
  between Evalomed Institute for Health Research Ltd.,
  and Juvena International AG for the development
  of a dietary supplement
· Technology concepts for 5 biodiesel and bioethanol
  plants in Brazil (in cooperation with Lurgi AG)

Contract Manufacturing and Packaging:

· Assessment of opportunities for manufacturing
  of OTC and ethical drugs in the Asia-Pacific
  for a major pharmaceutical company

Network:

· Core to BCP`s competencies is its network
  of leading European and Asian companies
  coordinating local co-development and
  business expansion services to meet the Client`s
  individual therapeutic and geographic needs.